155 related articles for article (PubMed ID: 38094413)
1. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
[TBL] [Abstract][Full Text] [Related]
2. Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Tan W; Peng S; Li Z; Zhang R; Xiao Y; Chen X; Zhu J; Li B; Lv X
Comput Math Methods Med; 2022; 2022():2021613. PubMed ID: 35069777
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
[TBL] [Abstract][Full Text] [Related]
5. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
[TBL] [Abstract][Full Text] [Related]
8. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9802197. PubMed ID: 38550132
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
International BR
Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
[TBL] [Abstract][Full Text] [Related]
14. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment.
International BR
Biomed Res Int; 2024; 2024():9786305. PubMed ID: 38550142
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9818549. PubMed ID: 38077877
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2023; 2023():9841321. PubMed ID: 38075334
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]